Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1996 Aug;55(8):520–524. doi: 10.1136/ard.55.8.520

Determination of IgA- and IgM-rheumatoid factors in patients with rheumatoid arthritis with and without nephropathy.

M Nakano 1, M Ueno 1, S Nishi 1, S Suzuki 1, H Hasegawa 1, T Watanabe 1, T Kuroda 1, S Ito 1, M Arakawa 1
PMCID: PMC1010231  PMID: 8774179

Abstract

OBJECTIVE: To clarify the characteristics and pathogenesis of renal disorders in patients with rheumatoid arthritis (RA). METHODS: In this study, 143 patients with RA were included, from whom 43 with urinary abnormalities were biopsied. Serum rheumatoid factor (RF) concentrations of IgA and IgM isotypes were also measured in these patients by enzyme linked immunosorbent assay. RESULTS: Light microscopy of renal biopsy specimens showed minor glomerular abnormalities in six patients, mesangial proliferative glomerulonephritis (GN) in 21, membranous nephropathy in seven, renal amyloidosis in seven, and tubulointerstitial nephritis in two. Twelve patients with mesangial proliferative GN and one with minor glomerular abnormalities were found by immunofluorescence microscopy to have abnormalities consistent with IgA GN. Although the concentrations of IgA-RF in patients with IgA GN were slightly raised compared with those with glomerulopathy established by biopsy but not associated with IgA GN, the concentrations of IgA-RF were higher in patients with RA with vasculitis or interstitial pneumonia than those with RA complicated by IgA GN. CONCLUSIONS: Mesangial proliferative GN, including IgA GN, may be a frequent renal lesion in Japanese patients with RA. IgA-RF may play little pathogenetic part in the development of IgA GN in RA.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., Healey L. A., Kaplan S. R., Liang M. H., Luthra H. S. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988 Mar;31(3):315–324. doi: 10.1002/art.1780310302. [DOI] [PubMed] [Google Scholar]
  2. Bampton J. L., Cawston T. E., Kyle M. V., Hazleman B. L. Measurement of rheumatoid factors by an enzyme-linked immunosorbent assay (ELISA) and comparison with other methods. Ann Rheum Dis. 1985 Jan;44(1):13–19. doi: 10.1136/ard.44.1.13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Beaman M., Adu D., Howie A. J., McConkey B., Michael J., Popert A. J. Rheumatoid arthritis and IgA nephropathy. Br J Rheumatol. 1987 Aug;26(4):299–302. doi: 10.1093/rheumatology/26.4.299. [DOI] [PubMed] [Google Scholar]
  4. Boers M. Renal disorders in rheumatoid arthritis. Semin Arthritis Rheum. 1990 Aug;20(1):57–68. doi: 10.1016/0049-0172(90)90095-w. [DOI] [PubMed] [Google Scholar]
  5. Bolton W. K., Schrock J. H., Davis J. S., 4th Rheumatoid factor inhibition of in vitro binding of IgG complexes in the human glomerulus. Arthritis Rheum. 1982 Mar;25(3):297–303. doi: 10.1002/art.1780250307. [DOI] [PubMed] [Google Scholar]
  6. Browning M. J., Banks R. A., Tribe C. R., Hollingworth P., Kingswood C., Mackenzie J. C., Bacon P. A. Ten years' experience of an amyloid clinic--a clinicopathological survey. Q J Med. 1985 Mar;54(215):213–227. [PubMed] [Google Scholar]
  7. Czerkinsky C., Koopman W. J., Jackson S., Collins J. E., Crago S. S., Schrohenloher R. E., Julian B. A., Galla J. H., Mestecky J. Circulating immune complexes and immunoglobulin A rheumatoid factor in patients with mesangial immunoglobulin A nephropathies. J Clin Invest. 1986 Jun;77(6):1931–1938. doi: 10.1172/JCI112522. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Davis J. A., Cohen A. H., Weisbart R., Paulus H. E. Glomerulonephritis in rheumatoid arthritis. Arthritis Rheum. 1979 Sep;22(9):1018–1023. doi: 10.1002/art.1780220911. [DOI] [PubMed] [Google Scholar]
  9. Doita M., Hirohata K., Maeda S. Association of HLA-DR antigens with disease severity in Japanese patients with rheumatoid arthritis. Kobe J Med Sci. 1990 Aug;36(3-4):103–114. [PubMed] [Google Scholar]
  10. Endoh M., Suga T., Sakai H. IgG, IgA and IgM rheumatoid factors in patients with glomerulonephritis. Nephron. 1985;39(4):330–335. doi: 10.1159/000183400. [DOI] [PubMed] [Google Scholar]
  11. Falck H. M., Maury C. P., Teppo A. M., Wegelius O. Correlation of persistently high serum amyloid A protein and C-reactive protein concentrations with rapid progression of secondary amyloidosis. Br Med J (Clin Res Ed) 1983 Apr 30;286(6375):1391–1393. doi: 10.1136/bmj.286.6375.1391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Fauchet R., Le Pogamp P., Genetet B., Chevet D., Guéguen M., Simon P., Ramée M. P., Cartier F. HLA-DR4 antigen and IgA nephropathy. Tissue Antigens. 1980 Nov;16(5):405–410. doi: 10.1111/j.1399-0039.1980.tb00322.x. [DOI] [PubMed] [Google Scholar]
  13. Garella S., Matarese R. A. Renal effects of prostaglandins and clinical adverse effects of nonsteroidal anti-inflammatory agents. Medicine (Baltimore) 1984 May;63(3):165–181. doi: 10.1097/00005792-198405000-00003. [DOI] [PubMed] [Google Scholar]
  14. Gertz M. A., Kyle R. A. Secondary systemic amyloidosis: response and survival in 64 patients. Medicine (Baltimore) 1991 Jul;70(4):246–256. [PubMed] [Google Scholar]
  15. Gioud-Paquet M., Auvinet M., Raffin T., Girard P., Bouvier M., Lejeune E., Monier J. C. IgM rheumatoid factor (RF), IgA RF, IgE RF, and IgG RF detected by ELISA in rheumatoid arthritis. Ann Rheum Dis. 1987 Jan;46(1):65–71. doi: 10.1136/ard.46.1.65. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hall C. L., Fothergill N. J., Blackwell M. M., Harrison P. R., MacKenzie J. C., MacIver A. G. The natural course of gold nephropathy: long term study of 21 patients. Br Med J (Clin Res Ed) 1987 Sep 26;295(6601):745–748. doi: 10.1136/bmj.295.6601.745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hall C. L. Gold nephropathy. Nephron. 1988;50(4):265–272. doi: 10.1159/000185185. [DOI] [PubMed] [Google Scholar]
  18. Hall C. L., Jawad S., Harrison P. R., MacKenzie J. C., Bacon P. A., Klouda P. T., MacIver A. G. Natural course of penicillamine nephropathy: a long term study of 33 patients. Br Med J (Clin Res Ed) 1988 Apr 16;296(6629):1083–1086. doi: 10.1136/bmj.296.6629.1083. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Helin H. J., Korpela M. M., Mustonen J. T., Pasternack A. I. Renal biopsy findings and clinicopathologic correlations in rheumatoid arthritis. Arthritis Rheum. 1995 Feb;38(2):242–247. doi: 10.1002/art.1780380213. [DOI] [PubMed] [Google Scholar]
  20. Helin H., Korpela M., Mustonen J., Pasternack A. Mild mesangial glomerulopathy--a frequent finding in rheumatoid arthritis patients with hematuria or proteinuria. Nephron. 1986;42(3):224–230. doi: 10.1159/000183671. [DOI] [PubMed] [Google Scholar]
  21. Helin H., Korpela M., Mustonen J., Pasternack A. Rheumatoid factor in rheumatoid arthritis associated renal disease and in lupus nephritis. Ann Rheum Dis. 1986 Jun;45(6):508–511. doi: 10.1136/ard.45.6.508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Hiki Y., Kobayashi Y., Tateno S., Sada M., Kashiwagi N. Strong association of HLA-DR4 with benign IgA nephropathy. Nephron. 1982;32(3):222–226. doi: 10.1159/000182849. [DOI] [PubMed] [Google Scholar]
  23. Hill G. S., Hinglais N., Tron F., Bach J. F. Systemic lupus erythematosus. Morphologic correlations with immunologic and clinical data at the time of biopsy. Am J Med. 1978 Jan;64(1):61–79. doi: 10.1016/0002-9343(78)90180-8. [DOI] [PubMed] [Google Scholar]
  24. Honkanen E., Törnroth T., Pettersson E., Skrifvars B. Membranous glomerulonephritis in rheumatoid arthritis not related to gold or D-penicillamine therapy: a report of four cases and review of the literature. Clin Nephrol. 1987 Feb;27(2):87–93. [PubMed] [Google Scholar]
  25. Hordon L. D., Sellars L., Morley A. R., Wilkinson R., Thompson M., Griffiths I. D. Haematuria in rheumatoid arthritis: an association with mesangial glomerulonephritis. Ann Rheum Dis. 1984 Jun;43(3):440–443. doi: 10.1136/ard.43.3.440. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Howard-Lock H. E., Lock C. J., Mewa A., Kean W. F. D-penicillamine: chemistry and clinical use in rheumatic disease. Semin Arthritis Rheum. 1986 May;15(4):261–281. doi: 10.1016/0049-0172(86)90022-3. [DOI] [PubMed] [Google Scholar]
  27. Husby G. Amyloidosis and rheumatoid arthritis. Clin Exp Rheumatol. 1985 Apr-Jun;3(2):173–180. [PubMed] [Google Scholar]
  28. Kelly C. A., Mooney P., Hordon L. D., Griffiths I. D. Haematuria in rheumatoid arthritis: a follow up study. Ann Rheum Dis. 1988 Dec;47(12):993–994. doi: 10.1136/ard.47.12.993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Kleinknecht D., Landais P., Goldfarb B. Analgesic and non-steroidal anti-inflammatory drug-associated acute renal failure: a prospective collaborative study. Clin Nephrol. 1986 Jun;25(6):275–281. [PubMed] [Google Scholar]
  30. Korpela M., Mustonen J., Helin H., Pasternack A. Immunological comparison of patients with rheumatoid arthritis with and without nephropathy. Ann Rheum Dis. 1990 Apr;49(4):214–218. doi: 10.1136/ard.49.4.214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Korpela M., Mustonen J., Pasternack A., Helin H. Mesangial glomerulopathy in rheumatoid arthritis patients. Clinical follow-up and relation to antirheumatic therapy. Nephron. 1991;59(1):46–50. doi: 10.1159/000186516. [DOI] [PubMed] [Google Scholar]
  32. Laakso M., Mutru O., Isomäki H., Koota K. Mortality from amyloidosis and renal diseases in patients with rheumatoid arthritis. Ann Rheum Dis. 1986 Aug;45(8):663–667. doi: 10.1136/ard.45.8.663. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Leonard P. A., Bienz S. R., Clegg D. O., Ward J. R. Hematuria in patients with rheumatoid arthritis receiving gold and D-penicillamine. J Rheumatol. 1987 Feb;14(1):55–59. [PubMed] [Google Scholar]
  34. McCoy R. C., Abramowsky C. R., Tisher C. C. IgA nephropathy. Am J Pathol. 1974 Jul;76(1):123–144. [PMC free article] [PubMed] [Google Scholar]
  35. McIntosh R. M., García R., Rubio L., Rabideau D., Allen J. E., Carr R. I., Rodríguez-Iturbe B. Evidence of an autologous immune complex pathogenic mechanism in acute poststreptococcal glomerulonephritis. Kidney Int. 1978 Nov;14(5):501–510. doi: 10.1038/ki.1978.155. [DOI] [PubMed] [Google Scholar]
  36. Miyazaki M., Endoh M., Suga T., Yano N., Kuramoto T., Matsumoto Y., Eguchi K., Yagame M., Miura M., Nomoto Y. Rheumatoid factors and glomerulonephritis. Clin Exp Immunol. 1990 Aug;81(2):250–255. doi: 10.1111/j.1365-2249.1990.tb03326.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Mustonen J., Pasternack A., Helin H., Nikkilä M. Clinicopathologic correlations in a series of 143 patients with IgA glomerulonephritis. Am J Nephrol. 1985;5(3):150–157. doi: 10.1159/000166925. [DOI] [PubMed] [Google Scholar]
  38. Mutru O., Laakso M., Isomäki H., Koota K. Ten year mortality and causes of death in patients with rheumatoid arthritis. Br Med J (Clin Res Ed) 1985 Jun 15;290(6484):1797–1799. doi: 10.1136/bmj.290.6484.1797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Pasternack A., Wegelius O., Mäkisara P. Renal biopsy in rheumatoid arthritis. Acta Med Scand. 1967 Nov;182(5):591–595. doi: 10.1111/j.0954-6820.1967.tb10885.x. [DOI] [PubMed] [Google Scholar]
  40. Perneger T. V., Whelton P. K., Klag M. J. Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs. N Engl J Med. 1994 Dec 22;331(25):1675–1679. doi: 10.1056/NEJM199412223312502. [DOI] [PubMed] [Google Scholar]
  41. Pollet S., Depner T., Moore P., Olander H., Robbins D. Mesangial glomerulopathy and IgM rheumatoid factor in rheumatoid arthritis. Nephron. 1989;51(1):107–111. doi: 10.1159/000185262. [DOI] [PubMed] [Google Scholar]
  42. Powell R. J., Leyland A. M., Pound J. D., Bossingham D. H. An improved assay for IgG rheumatoid factor: its value in the diagnosis of rheumatoid arthritis. J Rheumatol. 1985 Jun;12(3):427–431. [PubMed] [Google Scholar]
  43. Ramirez G., Lambert R., Bloomer H. A. Renal pathology in patients with rheumatoid arthritis. Nephron. 1981;28(3):124–126. doi: 10.1159/000182132. [DOI] [PubMed] [Google Scholar]
  44. STEINBROCKER O., TRAEGER C. H., BATTERMAN R. C. Therapeutic criteria in rheumatoid arthritis. J Am Med Assoc. 1949 Jun 25;140(8):659–662. doi: 10.1001/jama.1949.02900430001001. [DOI] [PubMed] [Google Scholar]
  45. Saito T., Nishi S., Karasawa R., In H., Hayashi H., Ueno M., Ogino S., Sugiyama N., Suzuki S., Maruyama Y. An ultrastructural study of glomerular basement membrane in rheumatoid arthritis patients with urinary abnormalities. Clin Nephrol. 1995 Jun;43(6):360–367. [PubMed] [Google Scholar]
  46. Salomon M. I., Gallo G., Poon T. P., Goldblat M. V., Tchertkoff V. The kidney in rheumatoid arthritis. A study based on renal biopsies. Nephron. 1974;12(4):297–310. doi: 10.1159/000180342. [DOI] [PubMed] [Google Scholar]
  47. Samuels B., Lee J. C., Engleman E. P., Hopper J., Jr Membranous nephropathy in patients with rheumatoid arthritis: relationship to gold therapy. Medicine (Baltimore) 1978 Jul;57(4):319–327. doi: 10.1097/00005792-197807000-00003. [DOI] [PubMed] [Google Scholar]
  48. Sandler D. P., Burr F. R., Weinberg C. R. Nonsteroidal anti-inflammatory drugs and the risk for chronic renal disease. Ann Intern Med. 1991 Aug 1;115(3):165–172. doi: 10.7326/0003-4819-115-3-165. [DOI] [PubMed] [Google Scholar]
  49. Sato M., Kojima H., Koshikawa S. IgA nephropathy in rheumatoid arthritis. Nephron. 1988;48(2):169–170. doi: 10.1159/000184903. [DOI] [PubMed] [Google Scholar]
  50. Scott D. G., Bacon P. A., Tribe C. R. Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases. Medicine (Baltimore) 1981 Jul;60(4):288–297. [PubMed] [Google Scholar]
  51. Sellars L., Siamopoulos K., Wilkinson R., Leohapand T., Morley A. R. Renal biopsy appearances in rheumatoid disease. Clin Nephrol. 1983 Sep;20(3):114–120. [PubMed] [Google Scholar]
  52. Sesso R. C., Ramos O. L., Pereira A. B. Detection of IgG-rheumatoid factor in sera of patients with acute poststreptococcal glomerulonephritis and its relationship with circulating immunecomplexes. Clin Nephrol. 1986 Aug;26(2):55–60. [PubMed] [Google Scholar]
  53. Shankel S. W., Johnson D. C., Clark P. S., Shankel T. L., O'Neil W. M., Jr Acute renal failure and glomerulopathy caused by nonsteroidal anti-inflammatory drugs. Arch Intern Med. 1992 May;152(5):986–990. [PubMed] [Google Scholar]
  54. Sinico R. A., Fornasieri A., D'Amico G. Role and clinical significance of rheumatoid factors in glomerulonephritis. Contrib Nephrol. 1988;61:149–155. doi: 10.1159/000415245. [DOI] [PubMed] [Google Scholar]
  55. Sinico R. A., Fornasieri A., Maldifassi P., Colasanti G., D'Amico G. The clinical significance of IgA rheumatoid factor in idiopathic IgA mesangial nephropathy (Berger's disease). Clin Nephrol. 1988 Oct;30(4):182–186. [PubMed] [Google Scholar]
  56. Ueda Y., Sakai O., Yamagata M., Kitajima T., Kawamura K. IgA glomerulonephritis in Japan. Contrib Nephrol. 1975;4:37–47. [PubMed] [Google Scholar]
  57. Westedt M. L., Herbrink P., Molenaar J. L., de Vries E., Verlaan P., Stijnen T., Cats A., Lindeman J. Rheumatoid factors in rheumatoid arthritis and vasculitis. Rheumatol Int. 1985;5(5):209–214. doi: 10.1007/BF00541338. [DOI] [PubMed] [Google Scholar]
  58. White E. G., Smith D. H., Zaphiropoulos G. C. Haematuria occurring during antirheumatoid therapy. Br J Rheumatol. 1984 Feb;23(1):57–60. doi: 10.1093/rheumatology/23.1.57. [DOI] [PubMed] [Google Scholar]
  59. van Zeben D., Hazes J. M., Zwinderman A. H., Cats A., Schreuder G. M., D'Amaro J., Breedveld F. C. Association of HLA-DR4 with a more progressive disease course in patients with rheumatoid arthritis. Results of a followup study. Arthritis Rheum. 1991 Jul;34(7):822–830. doi: 10.1002/art.1780340707. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES